• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Achaogen Inc. - Product Pipeline Review - H2 2011 Product Image

Achaogen Inc. - Product Pipeline Review - H2 2011

  • ID: 1964555
  • November 2011
  • 41 pages
  • Global Markets Direct

Achaogen Inc. – Product Pipeline Review – H2 2011

Summary

Global Market Direct’s pharmaceuticals report, “Achaogen Inc. - Product Pipeline Review - H2 2011” provides data on the Achaogen Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Achaogen Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Achaogen Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Achaogen Inc. - Brief Achaogen Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Achaogen Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, READ MORE >



List of Tables
List of Figures
Achaogen Inc. Snapshot
Achaogen Inc. Overview
Key Information
Key Facts
Achaogen Inc. – Research and Development Overview
Key Therapeutic Areas
Achaogen Inc. – Pipeline Review
Pipeline Products by Stage of Development
Achaogen Inc. – Pipeline Products Glance
Achaogen Inc. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Achaogen Inc.–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Achaogen Inc. – Drug Profiles
ACHN-490
Product Description
Mechanism of Action
R&D Progress
Broad-Spectrum FQ
Product Description
Mechanism of Action
R&D Progress
Expanded Spectrum Neoglycosides Development Program
Product Description
Mechanism of Action
R&D Progress
Fluoroquinolone Development Program
Product Description
Mechanism of Action
R&D Progress
LpxC
Product Description
Mechanism of Action
R&D Progress
MRSA
Product Description
Mechanism of Action
R&D Progress
Achaogen Inc. - Pipeline Products By Target
Achaogen Inc. – Pipeline Products by Route of Administration
Achaogen Inc. – Pipeline Products by Molecule Type
Achaogen Inc. – Recent Pipeline Updates
Achaogen Inc. - Dormant Projects
Achaogen Inc. – Locations And Subsidiaries
Head Office
Recent Developments
Aug 30, 2010: Achaogen Receives $64 Million Contract From BARDA For Development Of ACHN-490
Sep 14, 2009: Achaogen Announces ACHN-490 Clinical Data At The 49th Annual ICAAC Meeting
Feb 03, 2009: Achaogen Initiates Phase I Trial Of ACHN-490 For The Treatment Of Multi-Drug Resistant Gram-Negative Bacterial Infections
Financial Deals Landscape
Achaogen Inc., Deals Summary
Achaogen Inc., Pharmaceuticals & Healthcare, Deal Details
Venture Financing
Achaogen Raises $56 Million In Series C Financing Round
Achaogen Secures $26 Million In Series B Financing
Achaogen Raises $13 Million In Series A Financing Round
Partnerships
ChemDiv Enters Into Agreement With Achaogen
De Novo Pharmaceuticals Enters Into Co-Development Agreement With Achaogen
Albany Molecular Research Enters Into Research Agreement With Achaogen
NeoGenesis Pharmaceuticals Enters Into Co-Development Agreement With Achaogen
Licensing Agreements
Isis Pharmaceuticals Enters Into Licensing Agreement With Achaogen
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Achaogen Inc. – Pipeline by Therapy Area and Indication, H2 2011
Achaogen Inc. – Pipeline by Stage of Development, H2 2011
Achaogen Inc. - Phase II, H2 2011
Achaogen Inc. - Phase I, H2 2011
Achaogen Inc. - Pipeline By Target, H2 2011
Achaogen Inc. – Pipeline By Route of Administration, H2 2011
Achaogen Inc. – Pipeline By Molecule Type, H2 2011
Achaogen Inc. – Recent Pipeline Updates, H2 2011
Achaogen Inc. - Dormant Developmental Projects, 2010
Achaogen Inc., Deals Summary
Achaogen Raises $56 Million In Series C Financing Round
Achaogen Secures $26 Million In Series B Financing
Achaogen Raises $13 Million In Series A Financing Round
ChemDiv Enters Into Agreement With Achaogen
De Novo Pharmaceuticals Enters Into Co-Development Agreement With Achaogen
Albany Molecular Research Enters Into Research Agreement With Achaogen
NeoGenesis Pharmaceuticals Enters Into Co-Development Agreement With Achaogen
Isis Pharmaceuticals Enters Into Licensing Agreement With Achaogen

List of Figures
Achaogen Inc. – Pipeline by Therapy Area and Indication, H2 2011
Achaogen Inc. – Pipeline by Stage of Development, H2 2011
Achaogen Inc. - Pipeline By Target, H2 2011
Achaogen Inc. – Pipeline By Route of Administration, H2 2011

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos